Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
暂无分享,去创建一个
M. Yuen | D. Wong | J. Fung | D. But | J. Yuen | D. Fong | A. Chan | B. Wong | M. Mizokami | Yasuhito Tanaka | Ching‐lung Lai
[1] Ding‐Shinn Chen,et al. Association of pre‐S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.
[2] Y. Liaw,et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma , 2007, Gut.
[3] M. Yuen,et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels , 2007, Gut.
[4] J. Kao,et al. Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. , 2006, World journal of gastroenterology.
[5] Ding‐Shinn Chen,et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. , 2006, The Journal of infectious diseases.
[6] S. Sarin,et al. Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India , 2006, Journal of medical virology.
[7] Ding-Shinn Chen,et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. , 2006, The Journal of infectious diseases.
[8] Guan-Tarn Huang,et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.
[9] M. Yuen,et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications , 2005, Gut.
[10] V. Wong,et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma , 2004, Gut.
[11] Ching-Lung Lai,et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. , 2004, Carcinogenesis.
[12] M. Yuen,et al. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. , 2004, Journal of hepatology.
[13] M. Yuen,et al. Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion. , 2004, Journal of hepatology.
[14] M. Mizokami,et al. Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan , 2003, Intervirology.
[15] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[16] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[17] F. Sugauchi,et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. , 2003, Gastroenterology.
[18] Chee-Kin Hui,et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis‐related complications, and hepatocellular carcinoma , 2003, Hepatology.
[19] Ding‐Shinn Chen,et al. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.
[20] Makoto Arai,et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease , 2003, Hepatology.
[21] M. Mizokami,et al. Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan , 2002, Journal of medical virology.
[22] Chien-Jen Chen,et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.
[23] A. Tsubota,et al. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw , 2001, Journal of medical virology.
[24] T. Okanoue,et al. A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C , 2001, Hepatology.
[25] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[26] I. Lauder,et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience , 2000, Hepatology.
[27] M. Baptista,et al. High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black africans with hepatocellular carcinoma compared with asymptomatic carriers , 1999, Hepatology.
[28] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[29] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[30] R. Michael. B Virus Infection , 1966 .
[31] P. Loehrer,et al. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .
[32] M. Sherman. Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.
[33] E. Schiff,et al. Histological outcome during long-term lamivudine therapy. , 2003, Gastroenterology.